Keyword

RBX2660

Description: RBX2660 is an investigational microbiota-based therapeutic designed to prevent recurrent Clostridioides difficile infection by restoring gut microbial communities.
OpenAlex ID: keywords/rbx2660
2017 · John P. Mills, Krishna Rao, et al. · Current Opinion in Gastroenterology · 193
2023 · Anne J. Gonzales-Luna, Travis J. Carlson, et al. · Gut Microbes · 71
2016 · Jessica Martin, Mark Wilcox · Current Opinion in Infectious Diseases · 50
2023 · Nicolas Benech, Frédéric Barbut, et al. · Clinical Microbiology and Infection · 36
2023 · Anne J. Gonzales-Luna, Travis J. Carlson, et al. · Drugs · 36
2024 · Herbert L. DuPont, Andrew W. DuPont, et al. · Therapeutic Advances in Gastroenterology · 31
2023 · Paul Feuerstadt, Jessica R. Allegretti, et al. · The American Journal of Gastroenterology · 19
2024 · Abdelrahman Yakout, Yan Bi, et al. · Journal of Primary Care & Community Health · 18
Works count: 145
Citation count: 2,105
Year
Topic
Type